Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Total Liabilities (2021 - 2025)

Historic Total Liabilities for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $1.8 million.

  • HeartSciences' Total Liabilities fell 5177.14% to $1.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.8 million, marking a year-over-year decrease of 5177.14%. This contributed to the annual value of $4.0 million for FY2025, which is 8380.99% up from last year.
  • Per HeartSciences' latest filing, its Total Liabilities stood at $1.8 million for Q4 2025, which was down 5177.14% from $3.3 million recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Total Liabilities ranged from a high of $8.1 million in Q2 2022 and a low of $1.8 million during Q4 2025
  • Its 5-year average for Total Liabilities is $3.5 million, with a median of $3.5 million in 2022.
  • In the last 5 years, HeartSciences' Total Liabilities surged by 11228.37% in 2022 and then tumbled by 6247.29% in 2023.
  • Over the past 5 years, HeartSciences' Total Liabilities (Quarter) stood at $3.8 million in 2021, then decreased by 3.88% to $3.7 million in 2022, then increased by 8.95% to $4.0 million in 2023, then decreased by 6.41% to $3.8 million in 2024, then plummeted by 51.77% to $1.8 million in 2025.
  • Its Total Liabilities stands at $1.8 million for Q4 2025, versus $3.3 million for Q3 2025 and $4.0 million for Q2 2025.